ArticlePharmaceutics2024

Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design.

Milan Beljkas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.